Hasselbalch, Hans C. https://orcid.org/0000-0003-3936-8032
Skov, Vibe
Kjær, Lasse
Sørensen, Torben L.
Ellervik, Christina
Wienecke, Troels
Article History
Received: 23 January 2020
Accepted: 23 June 2020
First Online: 23 August 2020
Ethics approval and consent to participate
: Not applicable
: All authors have given consent for publication of the manuscript.
: Hans Carl Hasselbalch has received Novartis research grant and is a member of the advisory board for AOP Orphan.The other co-authors declare no competing financial interests.